Data / Form D filings / AmpliPhi Biosciences Corp
AmpliPhi Biosciences Corp: Form D filings
AmpliPhi Biosciences Corp, a biotechnology company in Glen Allen, VA, filed 6 Form D notices with the SEC between 2013 and 2015. The latest, on March 30, 2015, reports $13 million sold of a $13 million offering to 21 investors.
Find out what AmpliPhi Biosciences Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4870 SADLER ROAD, SUITE 300, Glen Allen, VA, 23060
- Phone
- (804) 205-5069
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 921114
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2015 | New notice | $13,000,000 | $13,000,000 | $0 | 21 | Mar 16, 2015 | sec.gov |
| Jan 2, 2014 | New notice | $18,001,750 | $18,001,750 | $0 | 26 | Dec 19, 2013 | sec.gov |
| Aug 8, 2013 | Amendment | $13,320,276 | $13,320,276 | $0 | 27 | Jun 26, 2013 | sec.gov |
| Jul 31, 2013 | Amendment | $13,320,276 | $13,320,276 | $0 | 27 | Jun 26, 2013 | sec.gov |
| Jul 10, 2013 | New notice | $12,490,999 | $12,490,999 | $0 | 8 | Jun 26, 2013 | sec.gov |
| Feb 25, 2013 | New notice | $7,500,000 | $500,000 | $7,000,000 | 1 | Feb 5, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Louis F. Drapeau | Director | |
| Wendy S. Johnson | Executive Officer, Director | |
| Baxter F. Phillips, III | Executive Officer | |
| Jeremy Curnock Cook | Executive Officer, Director | |
| David E. Bosher | Executive Officer | |
| Michael S. Perry | Director | |
| Anthony S. Smithyman | Director | |
| Julian P. Kirk | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Mar 30, 2015 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AmpliPhi Biosciences Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.